RIPK1 and neoplasm: Necrotic cell death in combination with PLX4720 in BRAFV600E melanoma independent from RIPK1 and RIPK3, tumor growth inhibition of BRAFV600E melanoma xenografts independent from caspase-3 activity in combination with vemurafenib